Large Scale Imputation of Drug Discovery Data using Deep Learning

Large Scale Imputation of Drug Discovery Data using Deep Learning

by Thanos Panagiotidis | May 27, 2020 | Cerella, Presentations and Webinars, Videos

Large Scale Imputation of Drug Discovery Data using Deep Learning Held on 26 May 2020. This webinar was presented by Ben Irwin and Matthew Segall (Optibrium), Tom Whitehead (Intellegens) and Scott Rowland (Takeda Pharmaceutical). We presented a case study in which...
AI-guided Design of Antimalarials with In Vitro Validation

AI-guided Design of Antimalarials with In Vitro Validation

by Thanos Panagiotidis | May 26, 2020 | Webinars

AI-guided Design of Antimalarials with In Vitro Validation This webinar was presented by Ben Irwin and Matthew Segall (Optibrium) and Professor Matthew Todd (University College London). In this webinar you can hear how a combination of generative chemistry and deep...
Translational Toxicology: Data visualisation across phases

Translational Toxicology: Data visualisation across phases

by Thanos Panagiotidis | May 13, 2020 | Presentations and Webinars, Videos

Translational Toxicology: Data visualisation across phases Held on 12 May 2020. This webinar was presented by Aishling Cooke and Matthew Segall. This webinar focused on the design of visualisation software for translational toxicology, with particular reference to the...

Optibrium Adopts Cheminformatics Toolkits From OpenEye Scientific

by Thanos Panagiotidis | May 12, 2020 | News

High performance libraries provide strong foundation for new developments to StarDrop drug discovery software CAMBRIDGE, UK and SANTA FE, NEW MEXICO, USA: 12 April, 2020 – Optibrium™ and OpenEye Scientific (OpenEye), leading providers of software and services for drug...

Recent Posts

  • Optibrium appoints Steve Yemm as Chief Commercial Officer
  • Introduction to StarDrop™
  • Real world case studies: Predicting pharmacokinetics from limited ADME data with deep learning
  • Inspyra™– Introduction
  • Cerella™– Introduction

Archives

Categories

  • Asteris
  • Cerella
  • Downloads
  • Drug Discovery Applications
  • Events
  • Example Code
  • General
  • In Silico Modelling
  • Latest Videos
  • Models
  • Multi-Parameter Optimisation
  • News
  • Ocura
  • Pipeline Pilot Protocols
  • Presentations and Webinars
  • Publications and presentations
  • Scoring Profiles
  • Scripts/Addons
  • StarDrop Hints and Tips
  • StarDrop Modules and Features
  • StarDrop Tutorials
  • Tutorials
  • Upcoming webinar
  • Videos
  • Webinars

Meta

  • Register
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

The Optibrium team works at the forefront of decision-analysis and predictive modelling research, developing innovative products that enhance the efficiency and productivity of drug discovery.

enquiries & support

General: [email protected]
StarDrop: [email protected]
Cerella: [email protected]
Press: [email protected]
Vacancies: [email protected]

  • Follow
  • Follow
further information

View our Privacy Policy

Copyright © 2023 Optibrium, Ltd. All Rights Reserved.
Optibrium™, StarDrop™, Augmented Chemistry®, Cerella™, Asteris™, Ocura™, Glowing Molecule™, WhichP450™, Auto-Modeller™, Nova™, MPO Explorer™ and Card View® are trademarks of Optibrium Ltd. Augmented Chemistry® is registered only in the UK and EU. Card View® is registered only in the United States. Matsy™ is a trademark of NextMove Software Ltd., BIOSTER™ is a trademark of iKem Szolgáltató és Kereskedelmi BT, Derek Nexus™ is a trademark of Lhasa Ltd., Surflex eSim3D is a trademark of BioPharmics LLC, and SeeSAR™ is a trademark of BioSolveIT GmbH. US Patent Numbers 9,224,098 and 9,367,812

Website designed and developed by Identity Creative.

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}